Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
letter
. 2008 Apr 15;105(17):E19. doi: 10.1073/pnas.0801034105

On BC1 RNA and the fragile X mental retardation protein

Claudia Bagni 1,*
PMCID: PMC2359794  PMID: 18417446

To the editor: Iacoangeli et al. (1) set out to reexamine our model that FMRP and the noncoding RNA BC1 act together to bind to mRNAs (2). Basing conclusions entirely on an inability to find this specific interaction, the authors suggest that FMRP and BC1 operate independently. Repeated statements suggesting experimental procedures are “replicating” those in ref. 2 imply the authors tried to rigorously reproduce our experiments. This is patently untrue. Numerous important experimental differences easily explain the negative results: different FMRP protein sources, different antibodies, and different experimental procedures.

Strikingly, many experiments in Iacoangeli et al. (1) lack adequate controls. For example, immunoprecipitations followed by RT-PCR lack controls for precipitation efficiency and/or mock precipitations for background. Conversely, our model has been substantiated by several outside laboratories: Henning Urlaub's laboratory reproduced the interaction between FMRP and BC1 by UV cross-linking (incorporated into ref. 3). Jean-Luc Darlix's laboratory reported very strong binding between BC1 to FMRP (Kd, 25 nM; ref. 4). Finally, Jennifer Gordon's laboratory demonstrated that MAP2, FMRP, dendritic mRNA, and BC1 coexist in vivo in the same complex (5), the starkest possible contradiction to the conclusion drawn by Iacoangeli et al. Finally, in collaboration with electrophysiologists, we've shown that a genetic interaction exists between BC1 and Fmr1 (6). All of these papers are either miscited or ignored in Iacoangeli et al. My laboratory is open to any kind of scientifically based discussion. However, because of the numerous technical flaws and incorrect and/or missing citations, Iacoangeli et al. does not provide compelling evidence against our published model.

Footnotes

The author declares no conflict of interest.

References

  • 1.Iacoangeli A, et al. On BC1 RNA and the fragile X mental retardation protein. Proc Natl Acad Sci USA. 2008;105:734–739. doi: 10.1073/pnas.0710991105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zalfa F, et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell. 2003;112:317–327. doi: 10.1016/s0092-8674(03)00079-5. [DOI] [PubMed] [Google Scholar]
  • 3.Zalfa F, et al. Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J Biol Chem. 2005;280:33403–33410. doi: 10.1074/jbc.M504286200. [DOI] [PubMed] [Google Scholar]
  • 4.Gabus C, et al. The fragile X mental retardation protein has nucleic acid chaperone properties. Nucleic Acids Res. 2004;32:2129–2137. doi: 10.1093/nar/gkh535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Johnson EM, et al. Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J Neurosci Res. 2006;83:929–943. doi: 10.1002/jnr.20806. [DOI] [PubMed] [Google Scholar]
  • 6.Centonze D, et al. Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome. Biol Psychiatry. 2007 doi: 10.1016/J.BIOPSYCH.2007.09.008. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES